« previous next »
Pages: [1]

Author Topic: Imaging biomarker diagnoses PML  (Read 116 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
Imaging biomarker diagnoses PML
« on: April 11, 2016, 05:27:44 pm »
There may be an imaging marker that identifies "T2 weighted hyperintensities that disseminate in a punctate pattern" prior to the appearance of PML in a patient--though the cause of the PML wouldn't be known. Such a test could be useful for MS patients taking Tysabri.

From NeurologyAdvisor.com, April 11, 2016:

http://www.neurologyadvisor.com/multiple-sclerosis/imaging-for-natalizumab-associated-pml/article/488806/
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
151 Views 		Last post November 02, 2018, 07:30:04 am
by agate
0 Replies
71 Views 		Last post July 31, 2019, 08:57:10 pm
by agate
0 Replies
32 Views 		Last post December 21, 2020, 09:44:40 pm
by agate
0 Replies
49 Views 		Last post March 15, 2021, 09:26:37 pm
by agate
0 Replies
34 Views 		Last post April 29, 2021, 08:03:54 pm
by agate